| Literature DB >> 18787317 |
Takashi Hasegawa1, Masaaki Saijo, Toshiyasu Ishii, Tomoko Nagata, Yuji Haishima, Nobuo Kawahara, Yukihiro Goda.
Abstract
A tadalafil analogue was detected in a dietary supplement marketed for tonic effect, along with hydroxyhomosildenafil and aminotadalafil. The tadalafil analogue was isolated by preparative thin layer chromatography (TLC) and its structure was elucidated using high-performance liquid chromatography (HPLC), liquid chromatography electrospray ionization-mass spectrometry (LC-ESI-MS), Fourier transform-ion cyclotron resonance-mass spectrometry (FT-ICR-MS) and nuclear magnetic resonance (NMR) spectroscopy. The compound was determined to be methyl-1-(1,3-benzodioxol-5-yl)-2-(chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18787317 DOI: 10.3358/shokueishi.49.311
Source DB: PubMed Journal: Shokuhin Eiseigaku Zasshi ISSN: 0015-6426 Impact factor: 0.464